Yamazoe et al. show that B cell-derived autoantibodies contribute to the development of atrial fibrillation, suggesting that targeting the humoral immune response may represent a viable therapeutic approach.
- Masahiro Yamazoe
- Kenneth K. Y. Ting
- Matthias Nahrendorf